Therefore, the target gene HOXA10 may affect the prognosis of patients with ovarian cancer by regulating dysregulated transcriptional pathways in cancer while affecting processes such as tumor proliferation, invasion, metastasis, epithelial mesenchymal transition, vascularization, and platinum chemoresistance. Here, HOXA10 is linked to ovarian carcinoma.